Xiangrui Jiang

2.0k total citations
79 papers, 1.0k citations indexed

About

Xiangrui Jiang is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Xiangrui Jiang has authored 79 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 25 papers in Organic Chemistry and 11 papers in Oncology. Recurrent topics in Xiangrui Jiang's work include Computational Drug Discovery Methods (10 papers), Synthesis and biological activity (7 papers) and Pharmacological Receptor Mechanisms and Effects (7 papers). Xiangrui Jiang is often cited by papers focused on Computational Drug Discovery Methods (10 papers), Synthesis and biological activity (7 papers) and Pharmacological Receptor Mechanisms and Effects (7 papers). Xiangrui Jiang collaborates with scholars based in China, Australia and United States. Xiangrui Jiang's co-authors include Jingshan Shen, Hualiang Jiang, Yechun Xu, Zhen Wang, Mingyue Zheng, Leike Zhang, He Yang, Qingjie Zhao, Ke Zen and Qiang Shao and has published in prestigious journals such as Nature Communications, Journal of Medicinal Chemistry and Green Chemistry.

In The Last Decade

Xiangrui Jiang

74 papers receiving 992 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangrui Jiang China 16 475 242 182 113 108 79 1.0k
Wenyu Wu China 20 470 1.0× 168 0.7× 80 0.4× 68 0.6× 115 1.1× 62 1.1k
Helena Almqvist Sweden 9 902 1.9× 115 0.5× 159 0.9× 76 0.7× 88 0.8× 12 1.3k
Jason Nowak United States 15 557 1.2× 122 0.5× 203 1.1× 35 0.3× 95 0.9× 20 1.1k
Farah Anjum Saudi Arabia 18 594 1.3× 119 0.5× 180 1.0× 95 0.8× 43 0.4× 72 1.0k
Yan Guan China 16 598 1.3× 81 0.3× 166 0.9× 79 0.7× 111 1.0× 26 1.0k
Huidong Yu China 18 489 1.0× 155 0.6× 300 1.6× 50 0.4× 34 0.3× 37 1.0k
Silvia Gervasoni Italy 15 360 0.8× 107 0.4× 123 0.7× 44 0.4× 48 0.4× 49 814
Natallia Strushkevich Belarus 15 462 1.0× 103 0.4× 118 0.6× 77 0.7× 56 0.5× 42 1.2k
Ahmed H.E. Hassan Egypt 23 449 0.9× 444 1.8× 118 0.6× 43 0.4× 61 0.6× 89 1.2k
Varnavas D. Mouchlis United States 20 654 1.4× 120 0.5× 331 1.8× 33 0.3× 47 0.4× 36 1.1k

Countries citing papers authored by Xiangrui Jiang

Since Specialization
Citations

This map shows the geographic impact of Xiangrui Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangrui Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangrui Jiang more than expected).

Fields of papers citing papers by Xiangrui Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangrui Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangrui Jiang. The network helps show where Xiangrui Jiang may publish in the future.

Co-authorship network of co-authors of Xiangrui Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangrui Jiang. A scholar is included among the top collaborators of Xiangrui Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangrui Jiang. Xiangrui Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Han, Yan Zhang, Ziyue Li, et al.. (2025). Screening and discovery of an antiviral candidate inhibiting the SARS-CoV-2 envelope (2-E) channel. Current Research in Microbial Sciences. 9. 100409–100409. 1 indexed citations
2.
Lu, Jie, Cheng Yan, Yumin Zhang, et al.. (2024). Design, synthesis, and evaluation of novel oxyacanthine derivatives for anti-SARS-CoV-2 activity. Bioorganic & Medicinal Chemistry Letters. 113. 129951–129951.
3.
Hu, Lun, et al.. (2024). Dual-channel hypergraph convolutional network for predicting herb–disease associations. Briefings in Bioinformatics. 25(2). 17 indexed citations
4.
Yang, Feipu, Yan Zhang, Guanghui Tian, et al.. (2024). Discovery of peptidomimetic spiropyrrolidine derivatives as novel 3CLpro inhibitors against SARS-CoV -2. European Journal of Medicinal Chemistry. 281. 117004–117004. 1 indexed citations
5.
Zhang, Yuxuan, Xingbang Yang, Fuqiang Zhu, et al.. (2024). Direct Reductive N‐alkylation of Amines with Carboxylic Esters. European Journal of Organic Chemistry. 28(1).
6.
Chen, Xinyao, Liping Zhou, Cheng Yan, et al.. (2024). Discovery of the potent covalent inhibitor with an acrylate warhead for SARS-CoV-2 3CL protease. Bioorganic & Medicinal Chemistry Letters. 112. 129942–129942. 2 indexed citations
7.
Wang, Jiangbo, et al.. (2024). Effect of storage temperature on the long term stability of Dendrobium catenatum Lindl. blended liquor. Journal of Food Measurement & Characterization. 18(4). 2618–2630. 1 indexed citations
8.
Zhang, Qian, Xinyao Chen, Aimin Zhou, et al.. (2024). F-CPI: A Multimodal Deep Learning Approach for Predicting Compound Bioactivity Changes Induced by Fluorine Substitution. Journal of Medicinal Chemistry. 68(1). 706–718. 1 indexed citations
9.
Yang, Wenjiao, Haiguo Sun, Chunhui Wu, et al.. (2023). Discovery of a CB2 and 5-HT1A receptor dual agonist for the treatment of depression and anxiety. European Journal of Medicinal Chemistry. 265. 116048–116048. 12 indexed citations
10.
Yang, Hanxi, Yan Zhang, Yan Zhang, et al.. (2023). Design, synthesis and biological evaluation of peptidomimetic benzothiazolyl ketones as 3CLpro inhibitors against SARS-CoV-2. European Journal of Medicinal Chemistry. 257. 115512–115512. 7 indexed citations
11.
Yang, Hanxi, Xinyao Chen, Qiumeng Zhang, et al.. (2023). Design, synthesis and biological evaluation of covalent peptidomimetic 3CL protease inhibitors containing nitrile moiety. Bioorganic & Medicinal Chemistry. 87. 117316–117316. 5 indexed citations
12.
Wang, Chun, Jie Lv, Ling Xie, et al.. (2023). TPN10475 alleviates concanavalin A-induced autoimmune hepatitis by limiting T cell development and function through inhibition of PI3K-AKT pathway. International Immunopharmacology. 125(Pt A). 111110–111110. 5 indexed citations
13.
Zhang, Yan, Jie Lv, Suqing Zhang, et al.. (2022). Synthesis and biological evaluation of artemisinin derivatives as potential MS agents. Bioorganic & Medicinal Chemistry Letters. 64. 128682–128682. 5 indexed citations
14.
Su, Haixia, Sheng Yao, Wenfeng Zhao, et al.. (2021). Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease. Nature Communications. 12(1). 3623–3623. 142 indexed citations
15.
Liu, Yin, et al.. (2021). Facile and Cost-Effective Route for the Synthesis of Simmerafil. Organic Process Research & Development. 25(11). 2432–2437. 1 indexed citations
16.
Yang, Feipu, Yu Wang, Chunhui Wu, et al.. (2019). Continuation of structure–activity relationship study of novel benzamide derivatives as potential antipsychotics. Archiv der Pharmazie. 352(4). e1800306–e1800306. 3 indexed citations
17.
Lu, Chunni, Damien Zanker, Peter Lock, et al.. (2019). Memory regulatory T cells home to the lung and control influenza A virus infection. Immunology and Cell Biology. 97(9). 774–786. 21 indexed citations
18.
Jiang, Tao, Zhuxi Chen, Peng Sun, et al.. (2015). Design, Synthesis, and Pharmacological Evaluation of Fused β-Homophenylalanine Derivatives as Potent DPP-4 Inhibitors. ACS Medicinal Chemistry Letters. 6(5). 602–606. 15 indexed citations
19.
Wang, Feng, Xiangrui Jiang, Lihong Hu, et al.. (2006). A Novel and Convenient Method for the Synthesis of Ubiquinone-10. Letters in Organic Chemistry. 3(8). 610–612.
20.
Jiang, Xiangrui, Lei Ao, Chang‐Xin Zhou, et al.. (2005). Synthesis and Biological Evaluation of Pyranone Analogues of Territrem B. Chinese Chemical Letters. 16(9). 1189–1192. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026